SEER Inquiry System - Report
Produced: 06/30/2024 10:16 PM
Question 20031100
Inquiry Details
References:
Clinical Oncology, 342-343. 8th Edition, Philip Rubin
Question:
Date of diagnosis: Can a positive VMA:HVA test be used as a date of diagnosis for neuroblastoma? See Description.
Discussion:
Rubin's Clinical Oncology states: Both the catecholamines and their metabolites are used as markers for neuroblastoma, with vanillylmandelic acid (VMA) and homovanillic acid (HVA) being the most commonly used. While their absolute values are not of prognostic significance, a higher VMA:HVA ratio suggests a better prognosis for patients with disseminated disease.
Answer:
No. Do not code the neuroblastoma diagnosis date from only the date of an elevated urine catecholamine test (VMA or HVA). This test is more prognostic than diagnostic. Neuroblastoma diagnosis should be made on the basis of tissue biopsy or bone marrow aspiration along with elevated urinary catecholamines. Elevated urinary catecholamines alone are not diagnostic of neuroblastoma.
Cancer Site Category:
N/A
Data Item Category:
Date of diagnosis
Other Category:
N/A
Year:
2003